184 related articles for article (PubMed ID: 25607558)
1. Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot study.
Mackay-Wiggan J; Marji J; Walt JG; Campbell A; Coppola C; Chakraborty B; Hollander DA; Whitcup SM
J Drugs Dermatol; 2014 Oct; 13(10):1232-9. PubMed ID: 25607558
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome.
Sherber NS; Hoch AM; Coppola CA; Carter EL; Chang HL; Barsanti FR; Mackay-Wiggan JM
Cutis; 2011 Feb; 87(2):96-103. PubMed ID: 21416778
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
4. Instability of topical ciclosporin emulsion for nail psoriasis.
Prins AM; Vos K; Franssen EJ
Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999
[No Abstract] [Full Text] [Related]
5. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
Scher RK; Stiller M; Zhu YI
Cutis; 2001 Nov; 68(5):355-8. PubMed ID: 11766122
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study.
Cannavò SP; Guarneri F; Vaccaro M; Borgia F; Guarneri B
Dermatology; 2003; 206(2):153-6. PubMed ID: 12592084
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
[TBL] [Abstract][Full Text] [Related]
10. Yellow nail syndrome in three siblings: a randomized double-blind trial of topical vitamin E.
Lambert EM; Dziura J; Kauls L; Mercurio M; Antaya RJ
Pediatr Dermatol; 2006; 23(4):390-5. PubMed ID: 16918641
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
[TBL] [Abstract][Full Text] [Related]
12. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
[TBL] [Abstract][Full Text] [Related]
14. Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome.
Williams HC; Buffham R; du Vivier A
Arch Dermatol; 1991 Jul; 127(7):1023-8. PubMed ID: 2064401
[TBL] [Abstract][Full Text] [Related]
15. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
de Jong EM; Menke HE; van Praag MC; van De Kerkhof PC
Dermatology; 1999; 199(4):313-8. PubMed ID: 10640840
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.
Veraldi S; Menter A; Innocenti M
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):290-6. PubMed ID: 18269596
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin administration improves clinical manifestations and quality of life in patients with 20-nail dystrophy: case series and survey study.
Lee YB; Cheon MS; Eun YS; Cho BK; Park YG; Park HJ
J Dermatol; 2012 Dec; 39(12):1064-5. PubMed ID: 22901077
[No Abstract] [Full Text] [Related]
20. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
